Onconova Therapeutics Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option

Published: Jul 31, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEWTOWN, Pa., July 30, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) today announced the closing of its initial public offering of 5,941,667 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts, including 775,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the same price to cover over-allotments. As a result, aggregate net proceeds to the Company, after underwriting discounts and commissions and other estimated offering expenses, were approximately $79.6 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news